Sort by 'comments'
High Risk Myeloma Treatment Options
Myeloma is classified as high-risk based on presence of cytogenetic abnormalities and poor treatment outcomes. Despite many new drugs and drug combinations being approved, long term benefits for high risk multiple myeloma patients is less clear. We continue our discussion…
Developments in Personalized Medicine and New Options in Breast Cancer Treatment
In this era of personalized medicine the standard "one dose fits all" approach to cancer care has been ineffective leading to treatment failures. Personalized medicine is a new healthcare paradigm that allows physicians to choose treatment methodology optimally based on…
Living Well with Prostate Cancer
Quality of life is a major concern of patients when they are choosing treatment for prostate cancer. Our prostate cancer panel led by Mike Scott is talking to Dr. Paul Schellhammer, a prostate cancer survivor himself, about treatment outcomes and…
Precision Medicine: Identifying Targeted Cancer Treatments with Genomic Testing
Precision, or personalized, medicine has made a sea-change in cancer treatment. A pipe dream for most patients 10 years ago, it is a reality today. Precision Medicine's keystone is the ability to identify personal gene characteristics and match them to…
Living well with Prostate Cancer – Part 2
We continue our discussion with Dr. Paul Schellhammer on prostate cancer and life thereafter. The prostate cancer panel led by Mike Scott will address how patients/advocates/caregivers can help the medical community develop new data that will provide better information on…